IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.

Transplantation · 2016 · PMC5120772 · PMID 26714123

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

At 6 months and 1 year follow-up, there was no statistically significant difference among groups regarding freedom from pulsed-steroid therapy, biopsy-confirmed rejection and infection requiring hospitalization, although group A showed a trend toward better freedom from pulsed-steroid therapy and biopsy-confirmed rejection than the other 2 groups ( Table 5; Table S1, SDC, http://links.lww.com/TP/B222 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.